Moreover, downregulation of SLC39A6 inhibits pancreatic cancer cell proliferation in vitro and reduces tumor growth and metastasis in vivo, which indicates the aggressive role of SLC39A6 in pancreatic cancer. The gene discussed is SLC39A6; the disease is familial pancreatic carcinoma.